Multisystem Flashcards
CHARGE syndrome
CHD7 gene mutation defined by a constellation of:
C: coloboma
H: heart defects
A: atresia choanae
R: retarded growth and development
G: genital hypoplasia
E: ear abnormalities and/or deafness
According to updated diagnostic criteria, the most defining features are the 4 Cs:
coloboma
choanal atresia
cranial nerve anomalies (especially olfactory pathway absence)
characteristic ear anomalies (especially semicircular canal dysplasia/aplasia)
Major criteria
coloboma (80%): ranges from defect of iris, retina, choroid, or disc, to microphthalmia or anophthalmia
choanal atresia/stenosis (45%) or cleft palate (25-50%)
cranial nerve anomaly/dysfunction
olfactory (90%): hyposmia/anosmia
facial (40%): facial palsy
vestibulocochlear (95-100%): sensorineural deafness
glossopharyngeal or vagal (60-80%): velopharyngeal incoordination for suck/swallow
characteristic ear anomalies (some or all of the following) (90%)
abnormal auricle: short and wide (lop/cup shaped), absent lobule, truncated helix, prominent antihelix
ossicular malformations
Mondini malformation
absent/hypoplastic semicircular canals
Minor criteria
urogenital abnormalities
kidney
duplex kidney
renal hypoplasia/solitary kidney
penis
hypospadias
penile agenesis
scrotum/testes
bifid scrotum
cryptorchidism
vaginal atresia
uterine atresia
congenital heart disease
tetralogy of Fallot
atrioventricular canal defect
double outlet right ventricle
short stature
cleft palate +/- lip
oesophageal atresia / tracheo-oesophageal fistula (~15%) 2
characteristic facies
developmental delay
Tuberous sclerosis features
Characterised by the development of multiple benign tumours of the embryonic ectoderm (e.g. skin, eyes, and nervous system).
H: hamartomas (CNS, retinal and skin)
A: angiofibroma (facial) or adenoma sebaceum
M: mitral regurgitation
A: ash-leaf spots
R: rhabdomyoma (cardiac)
T: tubers (cortical, subcortical)
O: autOsomal dominant (autosomal sounds like starting with letter “O” )
M: mental retardation (intellectual disability)
A: angiomyolipoma (renal)
S: seizures; Shagreen patches 1
Neurological
cortical/subcortical tubers: 50% are in the frontal lobe; high T2 and low T1 with only 10% of tubers showing enhancement; frequently calcify after two years of age
subependymal hamartomas: 88% are associated with calcification, although calcification absent in early childhood
subependymal giant cell astrocytomas (SGCA): tend to have intense enhancement
white matter abnormalities
retinal phakomas
rarer findings
cerebellar atrophy
infarcts (due to occlusive vascular disorders)
cerebral aneurysms
dysgenesis of the corpus callosum
Chiari malformations
microcephaly
arachnoid cysts
chordoma
Abdominal
renal angiomyolipoma (AML)
renal cysts
renal cell carcinoma and oncocytomas: occur at a younger age 1
retroperitoneal lymphangiomyomatosis (LAM)
retroperitoneal cystic lesions
gastrointestinal polyps
pancreatic neuroendocrine tumours
hepatic angiomyolipoma(s)
Thoracic
lymphangioleiomyomatosis (LAM)
multifocal micronodular pneumocyte hyperplasia (MMPH)
cardiac rhabdomyomas: typically regress before birth with spontaneous regression in 70% of children by age 4
thoracic duct and aortic/pulmonary artery aneurysm
myocardial fatty foci 14 / cardiac fat containing lesions 20
Musculoskeletal
sclerotic bone lesions: ~55% (range 40-66%)
hyperostosis of the inner table of the calvaria
periosteal new bone
scoliosis
bone cysts
Skin
Cutaneous lesions are present in ~95% of cases, but are rarely appreciated radiographically
hypopigmented macules (ash leaf spots): seen in 90% of patients 1
facial angiofibromas (Pringle nodules or adenoma sebaceum); seen in 75% of patients
fibrous plaques of the forehead (15-20%)
confetti lesions: variant of leukoderma spots
shagreen patches: seen in 20-30% of patients
periungual angiofibroma (Koenen tumours): 20% of patients
Genetics of tuberous sclerosis
Spontaneous mutations account for 50-86% of cases 3, with the remainder inherited as an autosomal dominant condition. In the majority of such cases (80%) the mutation has been narrowed down to two tumour suppressor genes, both part of the mTOR pathway 3,13:
TSC1: encoding hamartin, on chromosome 9q32-34
TSC2: encoding tuberin, on chromosome 16p13.3 (accounts for most cases)
Cowden syndrome
Also known as multiple hamartoma syndrome
====
The disease is characterised by:
mucocutaneous lesions: present in >90% of cases
gastrointestinal hamartomatous polyps (small and large bowel)
glycogenic acanthosis
thyroid abnormalities: thyroid adenomas, multinodular goitre
fibrocystic disease of the breast
testicular lipomatosis
=======
In addition to benign hamartoma formation, the syndrome carries a recognised increased risk of cancers such as:
breast cancer: develops in 30-50% of those with the syndrome
thyroid cancer: develops in 5% of those with the syndrome, usually follicular
CNS: dysplastic cerebellar gangliocytoma, occurs when in association with Lhermitte-Duclos disease (LDD)
======
Syndromic associations: group of disease known as PTEN-related diseases, which also includes:
1) Lhermitte-Duclos disease (LDD)
2) Bannayan-Riley-Ruvalcaba syndrome (BRRS)
Gardner syndrome
Inheritance?
Features?
Associated cancers?
Polyposis syndrome. Autosomal dominant inheritance in the FAP gene (chromosome 5q) in a majority of patients but with 20% of cases resulting from new mutations. Extracolonic features often precede the diagnosis of colonic polyps.
It is characterised by:
familial adenopolyposis
multiple osteomas: especially of the mandible, skull, and long bones
epidermal cysts
fibromatoses
desmoid tumours of mesentery and anterior abdominal wall
Other abnormalities include:
supernumerary teeth, odontomas and dentigerous cysts
duodenal tumours / ampullary carcinoma
papillary thyroid carcinoma
von Hippel-Lindau
Inheritance pattern?
Associated features?
ABDO
due to mutations in the VHL tumour suppressor gene on chromosome 3.
Autosomal dominant inheritance with high expression and penetrance; ~80% of cases occur via this pathway with ~20% arising de novo
HIPPEL
Mnemonic:
H: haemangioblastoma of CNS
I: increased risk of renal cell cancer
P: phaeochromocytoma
P: pancreatic lesions (cyst, cystadenoma, cystadenocarcinoma, neuro-endocrine tumours)
E: eye and ear dysfunction (retinal haemangioblastoma, endolymphatic sac tumours)
L: liver and renal cysts
RENAL (>67% of patients)
- renal cell carcinomas (RCCs): usually clear cell, frequently bilateral, 70% lifetime risk, RCC present at an earlier age (mean = 39 years)
- renal cysts: 75%, often bilateral and multiple, can be simple, complex or cystic renal cell carcinoma
- renal angiomyolipomas
ADRENAL
- phaeochromocytomas: 25-30% of patients
- extra-adrenal phaeochromocytoma / paraganglioma: 15%
PANCREAS (may be the earliest manifestation)
- pancreatic cysts: ~40% of patients
- pancreatic neuroendocrine tumours (pNET) and pancreatic serous cystadenoma: ~12.5% of patients
- pancreatic adenocarcinoma: rare
LIVER
- liver cysts
=========
Urogenital
=========
- epididymal cysts
- papillary cystadenoma of the epididymis: ~35%
- broad ligament cystadenomas
====
CNS
====
- CNS haemangioblastomas: ~70% of patients: cerebellar (~60%; range 44-72%), spinal cord (~30%; most commonly in the cervical and thoracic cord)
- choroid plexus papilloma
=============
Head and neck
=============
- retinal haemangioblastomas
- endolymphatic sac tumours (ELST): bilateral in 30%; considered pathognomonic for vHL
Multiple endocrine neoplasia - type 1
+ ?genetics
+associations
PPP or PiParPanc
Autosomal dominant genetic disease
===Pituitary adenoma===
prolactinoma (most common)
===Pancreatic neuroendocrine tumours===
gastrinoma (most common: >50%), followed by insulinoma (4-6%), and glucagonoma (<3%)
===Parathyroid proliferative diseases===
- parathyroid hyperplasia (most common): hyperparathyroidism (80-95%)
- parathyroid adenoma
- parathyroid carcinoma (rare)
Genetics
The abnormality is related to MEN1, a tumour suppressor gene located on chromosome 11q13 which produces menin, a nuclear protein important for the regulation of gene expression.
Associations
Numerous other lesions are encountered with greater frequency in patients with MEN1:
lipomas
angiofibromas
adrenal cortical lesions
adrenal adenomas
adrenocortical hyperplasia
cortisol-secreting adenomas
adrenal carcinomas (rare)
carcinoid tumours
hepatic focal nodular hyperplasia
breast carcinoma
meningiomas
Multiple endocrine neoplasia - type 2A
PMP
AD
===Phaeochromocytomas===
50% of patients, often bilateral, and can be extra-adrenal
===Medullary thyroid cancer===
100% of patients, aggressive, and may secrete calcitonin
===Parathyroid hyperplasia===
Only seen in 20% of patients, and often presents with hypercalcaemia and renal calculi
Genetics
A small proportion of individuals have a RET D631 proto-oncogene mutation. RET mutation is different from the RET translocation in papillary thyroid carcinoma. The chromosome locus is 10q11.2. 3
Multiple endocrine neoplasia - type 2B
PMMM
AD
===Phaeochromocytoma(s)===
in 50% of patients, often bilateral, and can be extra-adrenal
===Medullary thyroid cancer===
100% of patients; aggressive, and may secrete calcitonin
===Mucosal neuroma(s) / ganglioneuroma(s)===
===Marfanoid habitus===
Carney triad vs Carney complex vs Carney-Stratakis syndrome
Carney Complex has Cardiac findings (myxoma).
Associate “T” in GIST with Carney Triad; “X” in MyXoma can be associated with Carney compleX
==CARNEY COMPLEX==
multiple endocrine neoplasia syndrome characterised by:
- cardiac myxoma
often multiple, seen in two-thirds of patients with Carney complex - skin pigmentation (blue naevi): especially of the face, trunk, lips, and sclera
Multiple other features are also well recognised including:
extracardiac myxoma
breast
testis
thyroid
brain
adrenal gland: primary pigmented nodular adrenocortical disease (PPNAD)
pituitary adenoma
malignant melanotic nerve sheath tumour
testicular tumours
Sertoli cell tumours: most common
osteochondromyxoma
===CARNEY TRIAD===
is a rare syndrome defined by the coexistence of three tumours:
- extra-adrenal paraganglioma
initially, only functioning extra-adrenal paragangliomas were included, but subsequent work includes non-functioning extra-adrenal paragangliomas 1 - gastric gastrointestinal stromal tumours (GIST)
- pulmonary chondroma
In most cases, only two of the three tumours are present at the time of diagnosis, with the most common combination being GIST and pulmonary chondromas. Although not considered part of the triad, there is an increased incidence of adrenocortical adenoma, phaeochromocytoma, and oesophageal leiomyoma. It typically affects young people, with a female predilection. No underlying genetic mutation has been identified
====
Carney-Stratakis syndrome is a rare autosomal dominant condition comprising of familial paraganglioma and gastrointestinal stromal tumour (GIST).
====
Klippel-Trenaunay syndrome
very rare congenital disorder that is characterised by a triad of venous malformations, cutaneous capillary malformations, and limb overgrowth. It is considered an angio-osteo-hypertrophic syndrome.
Clinical presentation
Klippel-Trénaunay syndrome classically comprises a triad of:
cutaneous capillary malformations: port wine naevi
limb overgrowth: bony or soft tissue hypertrophy of an extremity (localised gigantism)
varicose veins or venous malformations of unusual distribution
The diagnosis of Klippel-Trénaunay syndrome is usually made when any two of the three features are present. Patients usually present in infancy. Features are often unilateral and typically affect one limb 2; capillary malformations may be absent in the atypical form 14. It may be diagnosed in utero 11.
Hypertrophy
Enlargement of the extremity consists of bone elongation, circumferential soft-tissue hypertrophy or both. This often manifests as leg-length discrepancy, although any limb may be affected. Hyperostosis frontalis interna has also been associated with Klippel-Trénaunay syndrome 23.
Capillary malformations
This is the most common cutaneous manifestation of Klippel-Trénaunay syndrome. Typically, capillary malformations involve the enlarged limb, although skin changes may be seen on any part of the body. The lower limb is the affected site in ~95% of patients.
Varicose veins
Present in a majority of patients with Klippel-Trénaunay syndrome, commonly located on the lateral aspect of the affected limb/leg 18 (and in some contradiction to common vena-saphena-magna varicosity). There may be persistence of embryonic veins, of which the lateral marginal vein (the vein of Servelle) has been the most typical finding (68-80% of patients) 22.
Venous malformations can occur in both the superficial and deep venous systems. Superficial venous abnormalities range from ectasia of small veins to persistent embryological veins and large venous malformations. Deep venous abnormalities include aneurysmal dilatation, aplasia, hypoplasia, duplications, and venous incompetence.
Visceral manifestations
Rectal and bladder haemorrhage are serious complications of pelvic vascular malformations and have been reported in 1% of cases 10. Vascular malformations can involve the:
gastrointestinal tract (20%)
bleeding is the most common symptom and range from occult bleeding to massive, life-threatening haemorrhages and consumptive coagulopathy
the most frequently reported sites are the distal colon and rectum
upper gastrointestinal bleeding from jejunal haemangiomas may also occur 19
genitourinary tract
involved in more severe cases
the absence of severe limb varicosities or venous malformations does not preclude the presence of pelvic involvement
gross haematuria, which is recurrent and painless, is usually the first clinical sign of bladder involvement and frequently manifests early in life
renal hypertrophy and venous enlargement may occur ipsilaterally to the affected side 15
vascular malformations are often located on the anterior bladder wall and dome
the trigone and bladder neck are rarely involved
genital lesions usually do not cause clinical problems for patients with Klippel-Trénaunay syndrome; however, some patients who report erectile dysfunction have abnormal penile veins
spleen
splenic haemangiomas may occur 7,20
Skeletal manifestations
These are usually secondary to leg-length difference 13:
ipsilateral hip dislocation
scoliosis
The name Klippel-Trénaunay-Weber syndrome is misleading as the current consensus uses two different names to denote two different syndromes. However, they are not always consistently addressed as distinct entities in the literature:
Klippel-Trénaunay syndrome is used in this article, whenever possible
Parkes Weber syndrome with true arteriovenous (AV) shunting
Sturg-Weber syndrome
Associations?
Sturge-Weber syndrome, or encephalotrigeminal angiomatosis, is a phakomatosis characterised by facial port wine stains and pial angiomas.
It is part of a wide spectrum of possible phenotypes included in the cerebrofacial arteriovenous metameric syndrome (CAMS).
Associations
- coarctation of aorta
- paragangliomas
Mnemonics
STURGE CAPS
S: seizures, sporadic
T: tram-track gyriform calcification; trigeminal territory port-wine stain
U: unilateral weakness (hemiparesis contralateral to facial naevus)
R: retardation
G: glaucoma, GNAQ gene
E: epilepsy
C: calvarial thickening, choroid plexus enlargement
A: atrophy of ipsilateral cerebral hemisphere
P: pial angiomatosis
S: sinus (paranasal) enlargement
8 Cs
congested veins in pial angiomatosis
cerebral atrophy
cortical tram track calcification
cavernous sinus enlargement
choroid plexus enlargement
calvarial thickening
choroidal haemangioma in the eye
cutaneous port-wine stain
PHACE syndrome
Epidemiology?
also known as cutaneous haemangioma–vascular complex syndrome or Pascual-Castroviejo type II syndrome, is a phakomatosis that comprises of:
P: posterior fossa malformations (e.g. Dandy-Walker malformation)
H: haemangiomas
A: arterial anomalies
C: coarctation of the aorta and cardiac anomalies
E: eye (ocular) anomalies
When sternal clefting and/or supraumbilical raphe are also present it is termed PHACES syndrome.
==Epidemiology==
PHACE syndrome is nine times more common in females
================
Clinical presentation
================
Clinical diagnosis of PHACE syndrome requires the presence of a characteristic segmental haemangioma or haemangioma >5 cm on the head (face or scalp) plus 1 major criterion or 2 minor criteria
Major criteria anomalies:
==arterial==
anomaly of major cerebral / cervical arteries (ICA, ACA, MCA, PCA, vertebral, basilar)
dysplasia of the large cerebral arteries (tortuosity, kinking, dolichoectasia)
arterial stenosis or occlusion with or without moyamoya collaterals
absence or moderate-severe hypoplasia of the large cerebral arteries
aberrant origin or course of the large cerebral arteries (except common aortic arch variants such as bovine aortic arch)
persistent carotid-vertebrobasilar anastomosis (persistent trigeminal, hypoglossal, proatlantal, or otic)
==structural brain==
posterior fossa anomalies
Dandy-Walker complex
midbrain/hindbrain hypoplasia/dysplasia
==ocular==
posterior segment anomalies
persistent hyperplastic primary vitreous
persistent fetal vasculature
retinal vascular anomalies
morning glory disc anomaly
optic nerve hypoplasia
peripapillary staphyloma
==cardiovascular==
aortic arch anomalies (except common variants such as bovine arch)
aortic coarctation
aberrant origin of subclavian artery
aortic aneurysm
==ventral or midline==
sternal defects or supraumbilical raphe
============
Minor criteria:
arterial:
intracranial aneurysm
structural brain:
midline anomalies
cortical malformations
ocular:
anterior segment anomalies
sclerocornea
cataract
coloboma
microphthalmia
cardiovascular:
ventricular septal defect
right aortic arch / double aortic arch
systemic venous anomalies
ventral or midline:
hypopituitarism
ectopic thyroid
sternal papule/hamartoma
Neurofibromatosis type 1
Criteria + genetics
also known as von Recklinghausen disease, is a multisystem neurocutaneous disorder, the most common phakomatosis, and a RASopathy. Additionally, it is also one of the most common inherited CNS disorders, autosomal dominant disorders, and inherited tumour syndromes.
The NF1 gene locus is on chromosome 17q11.2 and the gene product is neurofibromin, which acts as a tumour suppressor of the Ras/MAPK pathway;
==Clinical presentation==
As is the case with many phakomatoses, NF1 results in a variety of abnormalities of variable severity. To make the clinical diagnosis two or more of the following are required 2:
≥2 neurofibromas or ≥1 plexiform neurofibroma
optic nerve glioma
distinctive osseous lesion (such as sphenoid wing dysplasia or thinning of long bone cortex with or without pseudoarthrosis)
> 6 café au lait spots evident during one year (prepubertal >0.5 cm, postpubertal >1.5 cm in size)
axillary or inguinal freckling
≥2 iris hamartomas (Lisch nodules)
a primary relative with NF1
A mnemonic to help remember these features is CAFE SPOT.
In addition, ~45% (range 30-60%) of patients have learning disabilities, and approximately 1% have hypertension due to renal artery stenosis.
It is important to consider that NF1 has a much earlier age of onset than schwannomatosis and NF2, with approximately 50% of patients meeting the diagnostic criteria for NF1 by the age of 1 year and approximately 97% meeting the criteria by the age of 8 years
Neurofibromatosis type 1: Associated neoplasms
phaeochromocytoma
malignant peripheral nerve sheath tumour (MPNST) (~10% of patients)
Wilms tumour
rhabdomyosarcoma
renal angiomyolipoma
glioma
juvenile pilocytic astrocytoma (~20% of patients)
optic nerve glioma
diffuse brainstem glioma
spinal astrocytoma and spinal pilocytic astrocytoma
carcinoid tumour(s)
leiomyoma(s)
leiomyosarcoma
ganglioglioma
leukaemia